BridgeBio borrows $750M ahead of key PhIII readout, as it looks to wrap up buzzy 2021
The way BridgeBio tells it, it’s been up to some big things recently. And on Thursday, the biotech just got a whole lot more cash to turn its dreams into reality.
BridgeBio took out a $750 million loan on Thursday, separated into two tranches of $450 million and $300 million. The first, larger tranche will be available for BridgeBio to spend immediately, while the biotech can opt into the second, smaller tranche after one of two conditions related to its pipeline is met.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.